Compare Medtronic PLC (MDT) vs Phillips 66 (PSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Phillips 66 — how do they compare? Medtronic PLC trades at $82.57 (market cap $106.61B), while Phillips 66 trades at $210.49 (market cap $83.72B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | PSX | |
|---|---|---|
Market Cap | $106.61B | $83.72B |
Sector | Health | Energy |
52-Week High | $105.35 | $208.80 |
52-Week Low | $73.75 | $118.37 |
Enterprise Value | $125.36B | $105.69B |
Dividend Yield | 3.46% | 2.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
PSX trades at $209.47, up 1.26% on the day, with strong technical momentum and bullish moving average signals. The stock benefits from elevated refining margins and has beaten earnings expectations in three consecutive quarters. Recent news highlights its advantage from tight fuel markets and Middle East supply dynamics, while the company maintains a solid dividend payout of $1.27 per share.
Outlook remains positive with 57% analyst buy ratings and a consensus price target of $201.50, though current price exceeds this. Risks include volatile oil prices and declining revenue trends from $170B in 2022 to $132.4B in 2025. Institutional sentiment is supported by efficient refining operations and strategic positioning in current energy markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →
